Form 4: Oragenics Inc. Director Alan Dunton Sells Shares
SEC Form 4 Filing
Director Alan Dunton sold 66 shares of Oragenics Inc. common stock at $0.36 per share on December 6, 2024.
Summary
- Alan Dunton, a director of Oragenics Inc., sold 66 shares of the company's common stock on December 6, 2024.
- The sale was executed at a price of $0.36 per share.
- Following the transaction, Mr. Dunton directly owns 25,623 shares of Oragenics Inc.
Sentiment
Score: 5
Explanation: The document reflects a routine stock sale by a director, which is neither positive nor negative for the company's overall outlook.
Industry Context
This is a routine transaction for a company director and does not indicate any specific trend in the biotechnology industry.
Comparison to Industry Standards
- Director stock sales are common and are often part of personal financial planning.
- The volume of shares sold is relatively small compared to the total outstanding shares of the company.
- Similar transactions are regularly reported by directors and officers of publicly traded companies.
Stakeholder Impact
- The sale of shares by a director may have a minor impact on shareholder sentiment, but is unlikely to significantly affect the company's operations or value.
Key Dates
| Date | Description |
|---|---|
| 12/06/2024 | Date of the stock sale transaction. |
| 12/09/2024 | Date of signature for the SEC Form 4 filing. |
Keywords
Oragenics Inc, Alan Dunton, stock sale, director, share transaction, common stock
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.